News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn spinout REGENXBIO, co-founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, announced positive results from a phase II study for its treatment ABBV-RGX-314.
Interius has dosed its first patient in a clinical trial of its lead drug candidate, INT2104, an in vivoCAR T cell therapy that targets B-cell malignancies
This funding is a $10 million extension to its previous $15 million financing secured in November 2023.
Heirloom's proprietary and cost-efficient technology enhances limestone’s natural ability to capture carbon dioxide.
Philadelphia has built a strong foundation for its innovation ecosystem.
PCI’s ninth annual Celebration of Innovation took place at the Jordan Medical Education Center on December 4th.
The following Penn I-Corps teams showcased their technology on posters during the celebration.
Life Sciences Future took place in September, and offered a valuable opportunity for representatives from academia and the biotechnology, MedTech and pharmaceutical industries to connect.
During his time at PCI, David worked on a wide range of projects and hopes to eventually establish an innovation hub in Africa that will address intellectual property issues for Africans.
PCI and Yale Ventures hosted an event on September 17th entitled Innovators Ignite: A Penn & Yale Showcase, where aspiring and diverse academic entrepreneurs presented technologies.